The Transition From Rome III to Rome IV Irritable Bowel Syndrome: What We Gain and Lose

Clin Gastroenterol Hepatol. 2022 Mar;20(3):508-510. doi: 10.1016/j.cgh.2021.06.032. Epub 2021 Jun 29.

Authors

Andrea Shin¹, Lin Chang²

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
² Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California.

PMID: 34214681
DOI: 10.1016/j.cgh.2021.06.032

No abstract available

Keywords: IBS; Irritable Bowel Syndrome; Rome Criteria.

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Abdominal Pain
Diarrhea
Humans
Irritable Bowel Syndrome* / diagnosis
Rome

Grants and funding